A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC

Clinical trial NCT04108013 · UNKNOWN

Trial details

NCT number: NCT04108013
Sponsor: Xuanwu Hospital, Beijing
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Stage II PD-1 Antibody Non-small Cell Lung Cancer

Start date: 2019-10-08
Primary completion: 2021-07-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.